EquiSeq

EquiSeq is a private U.S. biotechnology company focused on equine genetic testing, particularly DNA-based tests for inherited muscle disease and exercise intolerance in horses. Its core commercial product is a myopathy testing panel that uses hair or blood samples to identify variants associated with conditions such as Muscle Integrity Myopathy, also referred to in company materials as PSSM2 and MFM. The company positions its tests for horse owners, breeders, veterinarians, and pre-purchase evaluation, with the goal of improving breeding decisions and long-term horse health. EquiSeq also highlights a broader research-driven platform built around equine genomics, bioinformatics, and patented methods for detecting inherited equine myopathies. While it is not a human therapeutics developer, it is healthcare-related within animal health and veterinary genomics.